Product Browser

Last updated: 2016/10/23

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

OPRS1 Pre-design Chimera RNAi

  • Catalog # : H00010280-R07
  • Visit Frequency :
  • Countries :
  • Specification
  • Product Description:
  • Homo sapiens opioid receptor, sigma 1 (OPRS1), transcript variant 2, mRNA.
  • Reactivity:
  • Human
  • Supplied Product:
  • DEPC water
  • Target Refseq:
  • NM_147157
  • Target Region:
  • 3' Untranslated Region (3'UTR)
  • Storage Instruction:
  • Store at -20°C, do not exceed 4 - 5 freeze-thaw cycles to ensure product integrity.
  • Note:
  • Position of the Chimera RNAi.
    The related RNAi products listed below were designed from different accesion number but sharing the same RNAi sequence.

  • Publication Reference
  • Applications
  • RNAi Knockdown
  • Application Image
  • RNAi Knockdown
  • Gene Information
  • Gene Name:
  • Gene Alias:
  • FLJ25585,MGC3851,OPRS1,SR-BP1
  • Gene Description:
  • sigma non-opioid intracellular receptor 1
  • Gene Summary:
  • This gene encodes a receptor protein that interacts with a variety of psychotomimetic drugs, including cocaine and amphetamines. The receptor is believed to play an important role in the cellular functions of various tissues associated with the endocrine, immune, and nervous systems. As indicated by its previous name, opioid receptor sigma 1 (OPRS1), the product of this gene was erroneously thought to function as an opioid receptor; it is now thought to be a non-opioid receptor. Alternative splicing of this gene results in transcript variants encoding distinct isoforms. [provided by RefSeq
  • Other Designations:
  • OTTHUMP00000000515,OTTHUMP00000000516,OTTHUMP00000000517,OTTHUMP00000021286,SR31747 binding protein 1,aging-associated gene 8 protein,opioid receptor, sigma 1,sigma1 receptor,type I sigma receptor
  • RSS
  • YouTube
  • Linkedin
  • Facebook